Dr. Julian D. Hardman, MD

Dr. Hardman practices at Spring Valley Hospital Medical Center in Las Vegas, Nevada, part of Universal Health Services.

Dr. Hardman's NPI, 1780908335, was assigned on March 24, 2010. Dr. Hardman graduated from University of Illinois College of Med (Chi/Peor/Rock/Chm-Urb) in 2010. Dr. Hardman holds Nevada license 17770.

Dr. Hardman's primary practice is Spring Valley Hospital Medical Center, at 5400 South Rainbow Blvd, Las Vegas, NV 89118 in Clark County. The practice phone is (702) 853-3000.

Dr. Hardman's primary practice is Spring Valley Hospital Medical Center in Las Vegas, Nevada, part of Universal Health Services. Dr. Hardman is also affiliated with Summerlin Hospital Medical Center. The medical group on file is Southwest Medical Associates. Dmand AI also links Dr. Hardman to 4 more hospitals, 2 group practices and clinics, 2 medical groups and 1 clinical lab, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hardman practices, 9 sites in all. Vendor and product names are available with a free account.

Diagnostic radiology is Dr. Hardman's primary specialty in the NPI Registry, under taxonomy code 2085R0202X. Dr. Hardman is licensed in Nevada.

CMS data shows 3,804 Medicare services from Dr. Hardman across 46 procedure codes in 2024, for 1,909 Medicare patients. Medicare paid $133,242 for them.

CMS counts 1,909 Medicare patients who saw Dr. Hardman in 2024. The largest group is 65 to 74, with 726 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 33% are also on Medicaid. Their average risk score is 2.24, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hardman's median patient age at 76, with 61% women.

In 2024, Dr. Hardman wrote 66 Medicare Part D claims for 33 patients. 94% of them were for generic drugs. CMS names the drug for 48 of them, across 1 drug with 11 or more claims each, at $286 in total drug cost. In 2023, CMS named 51 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Hardman for performance year 2024, reported individually. Dr. Hardman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 8 papers to Dr. Hardman, published from 2017 to 2021. 2017 was the busiest year, with 3. The most frequent topics are Intracranial Aneurysm, Aneurysm, Infected and Brain Ischemia. Dr. Hardman has published most often in Eur J Neurol. Dr. Hardman's most frequent co-authors are Ken Uchino, MD, Dolora R. Wisco and Andrew Blake Buletko.

CMS Open Payments shows 284 general payments to Dr. Hardman from 18 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 72% of the total. Penumbra, Inc. paid the most, $16,029.

Dr. Hardman graduated from University of Illinois College of Med (Chi/Peor/Rock/Chm-Urb) in 2010.